CClinicalTrials.gg
CompletedNCT04350879DMPKAUpdated Jun 16, 2022

Diabetes Mellitus and Pregnancy : Knowledge Assessment

An observational study in Diabetes Mellitus, sponsored by CHU de Reims. Completed at 1 site in France. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2022-06-16.

Sponsored by CHU de Reims · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
122
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Diabetes, a chronic and frequent disease, is a risk factor of pregnancy complications such as preeclampsia, congenital malformations and macrosomia.

Preconception care is all methods to assess the best prognostic for a diabetic pregnancy. Among these methods, contraception is very important to plan the pregnancy on a chosen moment.

The content of the preconception care is well established. However, information of diabetic women concerning contraception and giabetic pregnancy has been little studied.

Read the detailed description

The aim of the study is to describe the knowledge of the patients with diabetes concerning contraception and pregnancy planning.

02

Conditions studied

  • Diabetes Mellitus

Browse trials for

Keywords

  • Diabetes mellitus
  • pregnancy
  • contraception
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 122 is below the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

CHU de Reims is the lead sponsor of 267 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women between 18 and 40 years old, consulting in diabetology department of Reims Universitary Hospital and Charleville Mézières General Hospital

Inclusion criteria

  • Patients Aged between 18 and 40 years old
  • With type 1 or type 2 diabetes mellitus
  • Consulting in the department of diabetology in Reims and Charleville Mezieres hospitals
  • Accepting to participate in the study

Exclusion criteria

exclusion criteria :

  • Patients With secondary diabetes (endocrine, pancreatic or genetical origin)
  • With postmenopausal status
  • Without capacity to have a pregnancy (uterine aplasia, hysterectomy)
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
122 participants (actual)
Patient registry
No

Groups and cohorts

  • Diabetic patients

    Women between 18 and 40 years old with type 1 and type 2 diabetes

    Other: Data record

Interventions

  • OtherData record

    Data record

06

What researchers measure

Primary outcomes

  1. Risk of unplanned pregnancy

    Knowledge concerning the risk of unplanned pregnancy in diabete women

    Time frame: Day 0

07

Study locations

1 site
  • Damien JOLLY
    Reims, France
08

References and documents

Publications

  • Feutry L, Barbe C, Marquet-Dupont A, Fevre A, Lukas-Croisier C, Vitellius G, Delemer B, Barraud S. Contraception use and knowledge related to pregnancy in diabetic women. Ann Endocrinol (Paris). 2022 Apr;83(2):88-94. doi: 10.1016/j.ando.2022.01.007. Epub 2022 Feb 7. PubMed 35143750 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 16, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04350879
Lead sponsor
CHU de Reims
Responsible party
Sponsor
First posted
Apr 17, 2020
Start date
Mar 12, 2020
Primary completion
Jul 31, 2020
Completion
Sep 30, 2020
Last update
Jun 16, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion